Andreas Busch
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Absci Corp (ABSI)
Source not stated
Current -
Cyclerion Therapeutics, Inc. (CYCN)
Proxy statement
Current -
2022-01-01–2022-09-30
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Absci Corp (ABSI) | Chief Innovation Officer\ | $712,797 | $1,561,137 |
| 2024 | Absci Corp (ABSI) | Chief Innovation Officer\ | $654,095 | $2,644,420 |
| 2023 | Absci Corp (ABSI) | Chief Innovation Officer\ | $630,209 | $2,151,303 |
| 2022 | Absci Corp (ABSI) | Chief Innovation Officer\ | $149,602 | $4,732,732 |
| 2021 | Cyclerion Therapeutics, Inc. (CYCN) | Ph.D.,^\ ^ Chief Scientific Officer | $492,320 | $782,544 |
| 2020 | Cyclerion Therapeutics, Inc. (CYCN) | Ph.D.,^\ ^ Chief Scientific Officer | $479,667 | $806,919 |
| 2019 | Cyclerion Therapeutics, Inc. (CYCN) | Ph.D.,\ Chief Scientific Officer | $306,205 | $3,251,107 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.